Pre-Conference Workshop Day - Tuesday, December 7

Workshop A | 9:00am - 12pm EST

Mechanisms of Reimbursement for Novel Therapeutic Categories

Clinically validated digital therapeutics will need a new set of rules for pricing and reimbursement – and this is critical to DTx scale-up and wider adoption globally. In this hands-on session, Everett will be giving a short presentation followed by an interactive discussion with the audience on the following points. This is a unique opportunity to hear first-hand from Everett, CCO at Cognito Therapeutics and your fellow colleagues with guaranteed practical takeaways

  • Discussing how it really works
  • Gain clarity and understanding on the mechanisms of reimbursement to translate your research into viable business models
  • Discover real world examples of people who have accessed reimbursement to tailor your strategy
  • Ensure a viable business model by having a clear understanding of what payers are looking for

Workshop Leader:

Everett Crosland Headshot

Everett Crosland
Chief Commercial Officer
Cognito Therapeutics

Workshop B | 1:00pm - 5pm EST

Address & Tackle the Patient Engagement Conundrum by Hearing from Those Who Know It Best

  • Engaging in real life examples: learn how we can best tailor our DTx to our audience, ensuring sustained patient engagement
  • Discuss what it takes to get adoption, and what this means for strategy going forward
  • Exploring the importance of patient adoption & adherence on the continued and sustained success of DTx

Workshop Leaders:

Jen Horonjeff speaker

Jen Horonjeff
Founder & CEO
Savvy Cooperative

Theo Ahadome Headshot

Theo Ahadome
Head of BD & Alliance Management, DTx
Happify Health

Jessica Hauflaire picture

Jessica Hauflaire
Director of Operations
Digital Therapeutics Alliance